Queen’s Spin-out Company, QUBIS, in Bid to Revolutionize Cancer Diagnosis

Queen’s University has teamed up with a medical imaging company in a venture that has the potential to revolutionise cancer detection and treatment. The university’s spin-out company QUBIS has taken an equity shareholding in Cirdan Imaging, which develops imaging equipment to assist clinicians in the detection, diagnosis and treatment of cancer. The new devices will be used in diagnostic procedures, as well as cancer surgery, to better discriminate between healthy and malignant tissue.